Literature DB >> 1544294

Formal thought disorder in schizophrenia: a factor analytic study.

V Peralta1, M J Cuesta, J de Leon.   

Abstract

The Thought, Language and Communication Scale (TLC) was studied in a sample composed of 115 DSM-III-R schizophrenic patients admitted to an acute inpatient unit. A principal component analysis with varimax rotation was performed to explore the possibility of the existence of syndromes within the formal thought disturbances. Seven factors were found to have eigen values greater than 1 and five showed appropriate internal consistency. The first factor, or disorganization factor, was close to the Scale for the Assessment of Positive Symptoms (SAPS) formal thought disturbance subscale. The second, or negative factor (perseveration, poverty of speech and content), was moderately correlated with poor premorbid functioning and poor response to neuroleptic treatment. The third and fourth factors were, respectively, formed by stilted speech plus word approximations, and neologisms plus clanging. The fifth factor (distractibility and blocking), as well as the first two factors, were correlated to the Scale for the Assessment of Negative Symptoms (SANS) attention subscale.

Entities:  

Mesh:

Year:  1992        PMID: 1544294     DOI: 10.1016/0010-440x(92)90005-b

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  10 in total

Review 1.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

2.  Factor structure of the BPRS in deaf people with schizophrenia: correlates to language and thought.

Authors:  Heather K Horton; Steven M Silverstein
Journal:  Cogn Neuropsychiatry       Date:  2011-04-08       Impact factor: 1.871

3.  Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.

Authors:  Charity J Morgan; Michael J Coleman; Ayse Ulgen; Lenore Boling; Jonathan O Cole; Frederick V Johnson; Jan Lerbinger; J Alexander Bodkin; Philip S Holzman; Deborah L Levy
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

4.  Rethinking Thought Disorder.

Authors:  Mara Hart; Richard R J Lewine
Journal:  Schizophr Bull       Date:  2017-01-15       Impact factor: 9.306

5.  Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same?

Authors:  H Ziauddeen; C Dibben; C Kipps; J R Hodges; P J McKenna
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-08-15       Impact factor: 5.270

6.  Who does what to whom? graph representations of action-predication in speech relate to psychopathological dimensions of psychosis.

Authors:  Amir H Nikzad; Yan Cong; Sarah Berretta; Katrin Hänsel; Sunghye Cho; Sameer Pradhan; Leily Behbehani; Danielle D DeSouza; Mark Y Liberman; Sunny X Tang
Journal:  Schizophrenia (Heidelb)       Date:  2022-07-05

7.  Semantics, pragmatics, and formal thought disorders in people with schizophrenia.

Authors:  Carlos Salavera; Miguel Puyuelo; José L Antoñanzas; Pilar Teruel
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-07       Impact factor: 2.570

8.  Inner Speech and Clarity of Self-Concept in Thought Disorder and Auditory-Verbal Hallucinations.

Authors:  Paulo de Sousa; William Sellwood; Amy Spray; Charles Fernyhough; Richard P Bentall
Journal:  J Nerv Ment Dis       Date:  2016-12       Impact factor: 2.254

9.  Widespread cortical thinning, excessive glutamate and impaired linguistic functioning in schizophrenia: A cluster analytic approach.

Authors:  Liangbing Liang; Angélica M Silva; Peter Jeon; Sabrina D Ford; Michael MacKinley; Jean Théberge; Lena Palaniyappan
Journal:  Front Hum Neurosci       Date:  2022-08-05       Impact factor: 3.473

10.  Differences in single positive formal thought disorder symptoms between closely matched acute patients with schizophrenia and mania.

Authors:  Tilo Kircher; Frederike Stein; Arne Nagels
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-05-07       Impact factor: 5.270

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.